home.social

#incy — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #incy, aggregated by home.social.

  1. Incyte Japan wins MHLW approval for Minjuvi combo in 2L+ FL





    Key Terms

    non-hodgkin lymphoma

    medical


    A group of cancers that start in the lymphatic system, which is part of the body’s defense network of nodes and vessels; malignant cells multiply in lymph nodes, s…
    #Japan #JP #JapanNews #follicularlymphoma #INCY #Incyte #IncyteJapan #MHLWapproval #Minjuvi #news #oncology #tafasitamab
    alojapan.com/1431645/incyte-ja

  2. Incyte Japan wins MHLW approval for Minjuvi combo in 2L+ FL





    Key Terms

    non-hodgkin lymphoma

    medical


    A group of cancers that start in the lymphatic system, which is part of the body’s defense network of nodes and vessels; malignant cells multiply in lymph nodes, s…
    #Japan #JP #JapanNews #follicularlymphoma #INCY #Incyte #IncyteJapan #MHLWapproval #Minjuvi #news #oncology #tafasitamab
    alojapan.com/1431645/incyte-ja

  3. alojapan.com/1431645/incyte-ja Incyte Japan wins MHLW approval for Minjuvi combo in 2L+ FL #FollicularLymphoma #INCY #Incyte #IncyteJapan #Japan #JapanNews #MHLWApproval #Minjuvi #news #oncology #tafasitamab 
 
 
 
 
 Key Terms 
 
 non-hodgkin lymphoma
 
 medical
 
 
 A group of cancers that start in the lymphatic system, which is part of the body’s defense network of nodes and vessels; malignant cells multiply in lymph nodes

  4. alojapan.com/1431645/incyte-ja Incyte Japan wins MHLW approval for Minjuvi combo in 2L+ FL #FollicularLymphoma #INCY #Incyte #IncyteJapan #Japan #JapanNews #MHLWApproval #Minjuvi #news #oncology #tafasitamab 
 
 
 
 
 Key Terms 
 
 non-hodgkin lymphoma
 
 medical
 
 
 A group of cancers that start in the lymphatic system, which is part of the body’s defense network of nodes and vessels; malignant cells multiply in lymph nodes